CFR section
21 CFR 530.41(a): Drugs prohibited for extralabel use in animals
PART 530-EXTRALABEL DRUG USE IN ANIMALS · Subpart E-Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals
Key facts
| Citation | 21 CFR 530.41(a) |
|---|---|
| Section | Drugs prohibited for extralabel use in animals |
| Part | PART 530-EXTRALABEL DRUG USE IN ANIMALS |
| Subpart | Subpart E-Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals |
| Subchapter | 21 CFR E Drugs Animal |
| Product types cited | Food/Cosmetics, Veterinary |
| Regulation text (excerpt) | (a) The following drugs, families of drugs, and substances are prohibited for extralabel animal and human drug uses in food-producing animals. (1) Chloramphenicol; (2) Clenbuterol; (3) Diethylstilbestrol (DES); (4) Dimetridazole; (5) Ipronidazole; (6) Other nitroimidazoles; (7) Furazolidone. (8) Nitrofurazone. (9) Sulfonamide drugs in lactating dairy cattle (except approved use of sulfadimethoxine, sulfabromomethazine, and sulfaethoxypyridazine); (10) Fluoroquinolones; and (11) Glycopeptides… |
At a glance
- 100–999 Inspections citing this section
- 10–99 Warning letters citing this section
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About CFR sections cited by the FDA
Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.